- Home
- CMPX vs HFRO Comparison
CMPX vs HFRO Comparison
Compare CMPX & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- HFRO
- Stock Information
- Founded
- CMPX 2014
- HFRO 2000
- Country
- CMPX United States
- HFRO United States
- Employees
- CMPX N/A
- HFRO N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- HFRO Finance/Investors Services
- Sector
- CMPX Health Care
- HFRO Finance
- Exchange
- CMPX Nasdaq
- HFRO Nasdaq
- Market Cap
- CMPX 291.8M
- HFRO 287.7M
- IPO Year
- CMPX N/A
- HFRO N/A
- Fundamental
- Price
- CMPX $3.20
- HFRO $5.20
- Analyst Decision
- CMPX Strong Buy
- HFRO
- Analyst Count
- CMPX 9
- HFRO 0
- Target Price
- CMPX $12.67
- HFRO N/A
- AVG Volume (30 Days)
- CMPX 729.4K
- HFRO 179.8K
- Earning Date
- CMPX 08-11-2025
- HFRO 01-01-0001
- Dividend Yield
- CMPX N/A
- HFRO 8.87%
- EPS Growth
- CMPX N/A
- HFRO N/A
- EPS
- CMPX N/A
- HFRO N/A
- Revenue
- CMPX $850,000.00
- HFRO N/A
- Revenue This Year
- CMPX N/A
- HFRO N/A
- Revenue Next Year
- CMPX N/A
- HFRO N/A
- P/E Ratio
- CMPX N/A
- HFRO N/A
- Revenue Growth
- CMPX N/A
- HFRO N/A
- 52 Week Low
- CMPX $0.87
- HFRO $4.24
- 52 Week High
- CMPX $4.08
- HFRO $6.45
- Technical
- Relative Strength Index (RSI)
- CMPX 64.53
- HFRO 49.63
- Support Level
- CMPX $3.11
- HFRO $5.19
- Resistance Level
- CMPX $3.45
- HFRO $5.25
- Average True Range (ATR)
- CMPX 0.20
- HFRO 0.08
- MACD
- CMPX 0.01
- HFRO -0.01
- Stochastic Oscillator
- CMPX 69.33
- HFRO 60.71
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.